环原黄杨星C | 1936-70-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 环原黄杨星C
• 英文名称: cycloprotobuxine C
• 英文别名: (1S,3R,6S,8R,11S,12S,15S,16R)-15-[(1S)-1-(dimethylamino)ethyl]-N,7,7,12,16-pentamethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-amine
• CAS: 1936-70-5
• 化学式: C₂₇H₄₈N₂
• 分子量: 400.692
• InChiKey: PLKVWYPBRRRIQG-QGSMACLHSA-N

物化性质

• 沸点：
  466.6±18.0 °C(Predicted)
• 密度：
  1.01±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  29
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  环原黄杨星C 、 乙酸酐 在 吡啶 作用下， 生成 N-Acetyl-cycloprotobuxin-C
  参考文献：
  名称：

  摘要：

  DOI：

  10.1023/a:1024188831456
• 作为产物：
  描述：

  N-benzoylcycloprotobuxine-C 生成 环原黄杨星C
  参考文献：
  名称：

  摘要：

  DOI：

  10.1023/a:1024188831456

文献信息

• Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof
  申请人：XIAMEN SINOPEG BIOTECH CO., LTD.

  公开号：US10434182B2

  公开（公告）日：2019-10-08

  Disclosed are an eight-arm polyethylene glycol (PEG) derivative (formula I), production method therefor and modified bio-related substance thereby. Wherein, one tetravalent group U together with four trivalent groups Ec form a highly symmetrical octavalent group CORE0; Lc connects the octavalent group to eight PEG chains having polydispersity or monodispersity and having n1 to n8 as the degree of polymerization thereof; the terminal of one PEG chain is connected to at least one functional group F (k≥1); said PEG chain and F therebetween can be directly connected (g=0) or be indirectly connected via a linking group L0 to a terminal end-branching group G (g=1); the latter provides more reactive sites for binding more drug molecules and increases the drug loading. The eight-arm polyethylene glycol derivative has a centrosymmetric or approximately centrosymmetric structure, and leads to more precise control of the molecular weight in large-scale production and much narrower distribution of molecular weight for products. The modified bio-related substance thereby has a more uniform and controllable performance.

  本发明公开了一种八臂聚乙二醇（PEG）衍生物（式 I）、其生产方法及其改性生物相关物质。其中，一个四价基团 U 与四个三价基团 Ec 形成一个高度对称的八价基团 CORE0；Lc 将八价基团连接到八条具有多分散性或单分散性且聚合度为 n1 至 n8 的 PEG 链上；一条 PEG 链的末端与至少一个官能团 F 连接（k≥1）；所述 PEG 链和 F 之间可以直接连接（g=0），也可以通过连接基团 L0 与末端支化基团 G 间接连接（g=1）；后者提供了更多的反应位点，可以结合更多的药物分子，增加药物负载量。八臂聚乙二醇衍生物具有中心对称或近似中心对称结构，因此在大规模生产中可以更精确地控制分子量，产品的分子量分布也更窄。因此，改性生物相关物质的性能更均匀、更可控。
• [EN] BIO-RELATED SUBSTANCE MODIFIED BY MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE<br/>[FR] SUBSTANCE D'ORIGINE BIOLOGIQUE MODIFIÉE PAR UN DÉRIVÉ DU POLYÉTHYLÈNEGLYCOL MULTIFONCTIONNALISÉ<br/>[ZH] 一种多官能化聚乙二醇衍生物修饰的生物相关物质
  申请人：XIAMEN SINOPEG BIOTECH CO LTD

  公开号：WO2016050208A1

  公开（公告）日：2016-04-07

  本发明公开一种多官能化聚乙二醇衍生物（式1）修饰的生物相关物质。其具有H型结构，包括一个线性主轴LPEG及四个PEG分支链，n1、n2、n3、n4分别为分支链的聚合度；U1、U2为连接LPEG和两个PEG分支链的三价支化基团；F1、F2含有功能性基团或其被保护形式R01，且R01的个数为1个或多个。分子中任一个连接基或其与相邻杂原子基团形成的连接基可稳定存在或可降解；分子中任一个PEG链段各自独立地为多分散性或单分散性。1个H型分子可修饰多种或多个生物相关物质，修饰产物支化结构灵活，具有高载药量、可优化的药代动力学和组织分布情况，还可携带2种不同功能的生物相关物质，产生荧光性质或靶向功能。
• EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF
  申请人：XIAMEN SINOPEG BIOTECH CO., LTD

  公开号：US20180214561A1

  公开（公告）日：2018-08-02

  Disclosed are an eight-arm polyethylene glycol (PEG) derivative (formula I), production method therefor and modified bio-related substance thereby. Wherein, one tetravalent group U together with four trivalent groups E c form a highly symmetrical octavalent group CORE 0 ; L c connects the octavalent group to eight PEG chains having polydispersity or monodispersity and having n 1 to n 8 as the degree of polymerization thereof; the terminal of one PEG chain is connected to at least one functional group F (k≥1); said PEG chain and F therebetween can be directly connected (g=0) or be indirectly connected via a linking group L 0 to a terminal end-branching group G (g=1); the latter provides more reactive sites for binding more drug molecules and increases the drug loading. The eight-arm polyethylene glycol derivative has a centrosymmetric or approximately centrosymmetric structure, and leads to more precise control of the molecular weight in large-scale production and much narrower distribution of molecular weight for products. The modified bio-related substance thereby has a more uniform and controllable performance.
• ——
  作者：B. U. Khodzhaev、R. Shakirov

  DOI：10.1023/a:1024188831456

  日期：——